For many research scientists, the impact their researches have especially when it comes to betterment of human condition is important motivating factor. Having your work published by a journal that is reviewed by multiple highly qualified and professional peers is a golden opportunity that many research scientists look forward to. Since its founding in 2010, Oncotarget has dedicated itself to achieve this all important goal. Oncotarget publish research articles that are reviewed by multiple and experienced peers and a highly qualified editorial board headed by Andrei V. Gudkov together with Mikhail Blagosklonny who work as scientists at Roswell Park Cancer Institute and more information click here.
Multiple Quality Control Measures: Towards Greater Impact
Published weekly, Oncotarget is one of the fastest scientific journals globally. The growing popularity of the medical journal published by Impact Journals has been driven by several factors. Chief among these factors is the journal’s open access approach to publishing scientific work. Even though a hard copy of the journal can be availed with special request, all articles submitted and accepted by the journal are available online. The open access approach and tapping into the growing popularity of the online space have played a crucial role in the exponential growth of Oncotarget’s Impact Factor from 4.784 out of 493 citations in 2011 to 5.168 out of30241 citations during the 2016/2017 ranking year. Currently, the journal has an average impact factor of 5.415 for the five years leading up to the 2015/2015 evaluation. And its Facebook, It is leading oncology journal globally in terms of total documents published. This is an indication that more research scientists are using the open access platform presented by Oncotarget.
Additionally, the excellent ranking of Oncotarget has been driven by the strength, validity and constructiveness of its review process. Having hundreds of vastly experienced and qualified professionals carrying out multiple reviews on research articles submitted ensures that the articles published are of the highest quality. Oncotarget pride itself in having some of the best peer-reviews and editors in the various disciples the journal focuses on. By expanding the disciplines it focuses on from oncology to others such cell biology, cardiology and pharmacology among others, Oncotarget ensures that as many research scientists as possible can call it home and learn more about Oncotarget.
More Visit: https://twitter.com/oncotargetjrnl?lang=en